Trial Profile
Effects of valsartan on skeletal muscle fatty acid handling in patients with impaired glucose metabolism
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Sep 2013
Price :
$35
*
At a glance
- Drugs Valsartan (Primary)
- Indications Glucose intolerance
- Focus Pharmacodynamics
- 27 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
- 26 Sep 2013 New trial record